CD47 and neoplasm: There is evidence that relieving immunosuppression (e.g., blocking CD47 on tumor cells) can activate intra-tumoral DCs and crosstalk with NK cells [1], suggesting that innate checkpoints on DCs/macrophages are manipulable to improve DC function.